...
机译:用新型无选择方法表征尿液癌循环肿瘤细胞
The James Buchanan Brady Urological Institute and Department of Urology Johns Hopkins University;
The James Buchanan Brady Urological Institute and Department of Urology Johns Hopkins University;
The James Buchanan Brady Urological Institute and Department of Urology Johns Hopkins University;
The James Buchanan Brady Urological Institute and Department of Urology Johns Hopkins University;
The James Buchanan Brady Urological Institute and Department of Urology Johns Hopkins University;
The James Buchanan Brady Urological Institute and Department of Urology Johns Hopkins University;
The James Buchanan Brady Urological Institute and Department of Urology Johns Hopkins University;
The James Buchanan Brady Urological Institute and Department of Urology Johns Hopkins University;
The James Buchanan Brady Urological Institute and Department of Urology Johns Hopkins University;
机译:用新型无选择方法表征尿液癌循环肿瘤细胞
机译:基于尺寸的分离和无选择性技术的组合提供了比单独的转移前列腺癌患者单独的方法更高的循环肿瘤细胞检测灵敏度
机译:尿路上皮癌症循环肿瘤细胞及临床相关性的检测:两种方法的比较
机译:尿路上皮癌患者循环肿瘤细胞的体外培养与表征
机译:Toll样受体(TLR)的表达和具有循环肿瘤细胞的转移性乳腺癌患者免疫系统细胞的功能。
机译:基于裂隙滤滤场的循环肿瘤细胞捕获能力分析与多种癌症类型的无选择性方法相比
机译:CellSearch分离后用于乳腺癌循环肿瘤细胞下游表征的新方法
机译:前列腺癌循环肿瘤细胞的单细胞表征。